2 recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
| Phase 2 | 2 | Recruiting 2 |
Follow SpectraCure AB: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System Photodynamic Therapy (PDT), Verteporfin Injection - Prostate Cancer | Phase 1 / Phase 2 | Recruiting | SpectraCure AB | 43 | 2025-01-06 | 2026-05-01 |
| Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System Verteporfin, SpectraCure P18 System - Recurrent Prostate Cancer | Phase 1 / Phase 2 | Recruiting | SpectraCure AB | 66 | 2017-03-21 | 2026-05-01 |
Verteporfin (2) · Photochemotherapy (1)
United States (2) · Canada (1) · Germany (1) · Sweden (1) · United Kingdom (1)